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Obje&res, This experiment sought to determine the effect Of 
short.ternl administration of estrogen on endnt~e~ium.de~ndent 
dilation in the coronary arteries of !3 snr~ically 
female cynomolgus monkeys. 
kckground. Long-term estrogen replacement therapy pre- 
vents impaired endothelium~depcndent dilation of ath 
coronary arteries in postmenopausal female monkeys. 
remains unclear whether this action of estrogen is due to l0np 
term effects on plasma tipids and atherogenesis or to direct 
sh erm effects on the endothelium. 
The monkeys consnmcd an atherogenic diet for 18 
months after bilateral ovariectomy. Vascular responses were 
measured just before euthanasia and necropsy. Dextrose in water 
(control), acetylcholine, IO-%f, and nitroglycerin were infused 
Premenopnus& white women are at lower risk of coronary 
heart disease than white men of similar age (I ). However, 
coronary heart disease kills 250,000 women each year and is 
:P : leading cause of death in women >SO years old. Results 
of epidemiologic studies (3 indicate that estrogen replace- 
ment reduces the risk of first cardiovascular events by 50% 
in previously healthy postmenopausal women. In women 
with existing coronary heart disease, the beneficial effects of 
estrogen replacement may be even more dramatic. Sullivan 
et al. (3) reported that postmenopausal women with angio- 
graphically defined coronary artery disease who were taking 
estrogen replacement therapy had a 14% mortality rate at IO 
years compared with a 35% mortality rate in similar women 
not taking estrogsn. Likewise, in the Lipid Research Ginics 
Follow-up Study (4) the relative risk of death from corunary 
heart disease among women taking estrogen compared with 
that of other women was 0.19. 
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ection of etbil~y~ estra 
0.05). Coronury arteries dilate 
~o~~c~~i~~ov~~. Estrogen 
on ~vitbin 20 min 
ts on the vascular en 
One porcntial mcc for the prolective e 
estrogen is through its beneficial effects on plasma lipopro- 
teins by increasing high density lipoprotein (HDL) choles- 
terol and decreasing low density lipoprotein (L 
tcrol(2). However, in the Lipid Research Ciinics Follow-up 
Study (4). only 50% of the beneficial effect on mortality due 
to coronary heart disesc could be explained by changes in 
plasma lipid concentrations. This finding suggests that there 
may be independent cardioprotective effects of estrogen, 
such as a direct inhibitory infuence on atherogenesis, throm- 
bosis or vasospasm. 
Atherosclerotic coronary arteries have impaired endothe- 
lial function, resulting in impaired dilator and augmented 
constrictor responses to a variety of neurohumoral stimuli 
(5). Impaired vasomotor responses of atherosclerotic coro- 
nary arteries may contribute to the pathogenesis of coronary 
vasospasm. which may result in transient myocardial isch- 
emia or may promote plaque rupture, thrombosis and myo- 
cardial infarction. Variant angina due to coronary artery 
spasm is believed to be more frequent in women than in men 
(6). Results of studies (7) in surgically menopausal monkeys 
have indicated that long-term estrogen replacement therapy 
prevents impaired endothelium-dependent dilation ofathero- 
sclerotic coronary arteries. However, it remains undeter- 
mined whether estrogen affects endo:helium-dependent va- 
somotion through its long-term effects on plasma lipid 
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weeks before n cropsy. Procedens used in this experiment 
co rm to the “Position of the American Heart Association 
011 search Animal Use” adopted November E I, 1984 L) 
ciation. 
fits. ~~rc~lati~g conce~t~~tio~s of 
were measured with the techniques of 
Lahteenmaki and Nilsson (8). Total plasma ch 
measured with the methods of Allain et al. (9). 
cholesterol concentrations were determined a 
the Manual of Laboratory Operations ofthe Lipid Research 
Clinics Program (10). Blood pressure and heart rate mea- 
surements were made with a model 1245 or 1255 Dinamap 
Research monitor (Critikon). This method has been vali- 
dated for indirect measurement of blood pressure and heart 
rate in cynomolgus monkeys (11). 
easurement of vascular responses in ewotaary arteries. 
lar responses of the coronary artery were measured 
just before euthanasia and necropsy. onkeys were anes- 
thetized with ketamine hydrochloride (10 to I5 mg/kg body 
weight intramuscularly) and butorphanol (0.025 pgglkg intra- 
muscularly). Periodic doses of both agents were given to 
maintain light a..,, nncthcsia and the animals were allowed to 
breathe spontaneously. A catheter was inserted into the right 
femoral artery and advanced to the midthoracic aorta for 
measurement of blood pressure and heart rate. A custom- 
designed 3F (tapered to 1 .W) catheter was inserted into the 
left femoral artery and advanced into the left main coronary 
artery with fluoroscopic guidance. Blood pressure was mon- 
itored from the tip of the coronary catheter to exclude 
damping and significant obstruction ofcoronary olood flow. 
With use of an infusion pump (Harvard Apparatus), serial 
2.5-min intracoronary infusions were made in the following 
sequence: I) 5% dextrose inwater (control); 2) acetylcholine 
(dextrose) infusion. 
gly~erk on blood pressure 
infusions was not ~a~~o~~i~e 
~a~tjtat~ve coronary a~~~io~ra~by 
for analysis based on clarity of the image of the proximal 2 to 
3 cm of the circumflex coronary artery. Criteria for ciarity 
included maximal opacification, no overlapping structures 
and m~~irna~ motion artifact 1 
digitized with use of H Clpro 
Digitrorr remote wnrk station ( 
tative angiographic software ~~ai~maso~ics)~ s 
ified for the Image Analysis Laboratory, was I
edges of the vessel segment of interest and measure their 
average pixel diameter. The same segment of artcry was 
analyzed after each of the six infusions, The entire pr’jcess 
of frame selection and quantitative a~~iogra~b~c analysis 
an investigator who did not know 
sis. The results from the two ana 
highly correlated (r = 0.90). The average ofthe re 
analyses was used to calculate the percent change in pixel 
diameter from the baseline associated with each infusIon. 
easureme& of coronary artery at 
keys were euthanized with sodium pe~tobarbital (80 mglkg 
intravenously) after angiography. The cardiovascular system 
was then flushed with normal saline solution and perfused 
with 10% neutral buffered formalin at a pressure of 
100 mm Hg for 1 h. The heart was immersed in IO% neutral 
buffered formalin. hometric analysis of plaque size was 
obtained for the I cumflex coronary ariery (the ery 
used for measurements of vascular responses). Five rial 
tissue blocks were cut at approximately 3-mm intervals and 
lar to the long axis of the left circumflex car 
istologic sections were stained with Ver 
van Gieson’s stain. These sections were projected, and 
cross-sectional area of plaque lesion was measured with a 
digitizer. Atherosclerosis extent was expressed as the mean 
cross-sectional area of the intima in square millimeters. 
454 WILLIAMS ET AL. 
VASCULAR EFFECTS OF SHORT-TERM ESTROGEN THERAPY 
JACC Vol. 20. No. 2 
August 1992:452-7 
Table 1, Cardiovascujar Variables in 13 Ovariectomized Monkeys 
Before and After fntravenogs Administration of Ethinyl Estradiol 
Before Estrogen After Estrogen 
TPC (mg/dl) 655 c 33 669 ” 27 
HDLC (mg/dl) 43 c 4 45 + 7 
TPUHDLC 17 + 4 I8 + 5 
Systolic blood pressure (mm Hg) %?4 94 + 5 
Diastolic blood pressure (mm Hg) 54 r 2 51 t3 
Heart rate (beatslmin) 131 2 23 145 + 30 
Intimal area (mm*1 - 0.4 ct 0.1 
HDLC = high density lipoprotein cholesterol; TPC = total plasma 
cholesterol. 
$t~ti~ti~s, A paired Student I lost was used to compare 
the e&cts of acute administration f estrogen on plasma 
lipid concentrations, blood prcssurc, heart rate and vascular 
responses of coronary arteries. The Pearson product- 
moment correlation was u ed to determine if lhe vascuiar 
responses toacctylcholine and nitroglycerin were associated 
with plasma lipids, blood prcssurc. heart rate or intimal area. 
strogen concentrations. Intravenous injection of 54 ng of 
yl estradiol into three monkeys resulted in plasma 
concentrations of 350, 275 and 310 pgIm1. Ethinyl estradi E! -
concentrations i  the plasma of these monkeys befJ:e estro- 
gen treatment were below the tImits of detectlcin c: the assay 
(<2C pglml). 
Cardiovascuilar variables (Table 1). Intravenous infusion 
of estrogen did not alter concentrations of total plasma 
cholesterol, high density lipoprotein cholesterol rthe ratio 
between the two (p > 0.05 vs. before strogen). Inaddition, 
short-term administration f estrogen did not alter diastolic 
blood pressure, systolic blood pressure or heart rate (p > 
0. s. before strogen). 
orp~ol~y and mar 
There was modewte intimal thickening in the coronary 
arteries of all monkeys. Figure I shows a representative 
histologic section of a circumflex coronary artery from one 
ot‘the monkeys. The mean intimal area (plaque size) of the 
left circumflex coronary artery from the 13 monkeys used in 
this experiment is shown in Table I. 
VOUCH responses (Fig. 2). Infusion of ethinyl estradiol 
did not affect diameter at rest of the coronary arteries (5.5 + 
1 pixels VS. 5.7 2 1, p > 0.05). Before administration f 
estrogen, intracoronary i fusion of nitroglycerin resulted in 
dilation of the left circumflex coronary artery by 10 2 3% 
compared with control diameter. After administration f 
estrogen, dilator esponses to nitroglycerin (12 2 3%) were 
unchanged (P> 0.05 vs. before strogen), Before adminis- 
tration Of estrogen, intracoronary infusion of acetylcholine 
caused constriction (- I7 f 3%) of the left circumflex 
coronary artery. After administration of estrogen, acetylcho- 
line caused ilation (5 * 3%) of the coronary artery (p < 0.05 
VS. before strogen), 
Figure 1. Histologic section of a left circumilex coronary artery 
from an ovariectom;zed female monkey fed an atherogenic diet for 
22 months. Intimal arca is 0.4 mm’. The arrow pomts to the internal 
elastic laminae. Verhoeff-van Gieson stain; original magnification 
x.24. 
Vascular esponses to nitroglycerin and acetylcholinr 
either before or after administration f estrogen were not 
associated with variations in total plasma cholesterol, high 
density lipoprotein cholesterol, diastolic blood pressure, 
systolic blood pressure, heart ra e or intimal area (r < 0.50; 
r = 0.553 required for statistical significance atp < 0.35). 
The two major findings of this study are that among 
surgically postmenopausal female monkeys with diet- 
induced coronary artery atherosclerosis I) vascular e- 
sponses of coronary arteries to the endothelium-mediated 
dilator acetylcholine were altered from net constriction to 
net dilation within 20 min after infusion of ethinyl estradiol; 
and 2) vascular responses, both before and after estrogen, 
were not associated with variations in plasma lipid concen- 
trations, blood pressure, heart rate or plaque size. 
FORE Wl=TEFt 
Figure 2. individual data oints demonsuating percent change in 
coronary artery diameter conlpared with he conrrol diamerer. 
Arterial responses were measured before estrogen and 20 min after 
inlravenoul; infusion of ethinyl estradiol (tcft) ilod in rcsponsc to 
intracoronary infusion of acetylchnline aud nitroglycerin tright) (p <: 
0.05 fur acetylcholine VS. before estrogen treatmenl). 
Zawadski B 13) first 8’6” 
an obligatory role in 
isolated rabbit arteries. 
This observation reconcil 
the powerful vasodilator 
plier contradictory findings of 
of acetylchohne in the intact 
ction that it caused in 
arteries in which the endothehum was 
Acetylcholine acts on the arterial wall 
rinic receptors on endothelial cells and vascular smooth 
muscle cells (14). The direct ct of acetylcholine on 
smooth muscle is constriction. ever, acetylchoiine acts 
through the endothelium to cause release of e~dothe~i~m- 
derived relaxing factors that diffuse to the \::~xxlar smooth 
muscle, resulting in dilation of arteries (14). In arteries with 
normally functioning e~dotbe~ium, the endothelial effects of 
acetylcholine predominate, resulting in vasodilatiou. In ar- 
teries with damaged or removed endothelium, the smooth 
sts of acetylcbo~~~e predominate, resulting in 
vasoconstriction (14). 
Harrison et al. (15) reported that in monkeys studied in 
vitro nonatherosclerotic arteries dilated and atherosclerotic 
arteries constricted in response to acetylcholine. It was 
concluded from their study that atherosclerosis impaired the 
function of lumen endothehal cells, thereby causing para- 
doxic constriction previously observed (13) in endothelium- 
denuded arteries. Ludmer et al. (5) used quantitative angi- 
ography to examine vascular responses of coronary arteries 
in patients with and without angiographically defined coro- 
nary artery atherosclerosis. Acetylcholine caused parado:tic 
constriction of atherosclerotic and dilation of angiographi- 
tally normal arteries, suggesting ;hat severe atherosclerosis 
im s endothelium-mediated dilation of coronary arteries. 
salts Qf the present stln y. Previous studies from our 
laboratory (7,16) have established quantitative angiography 
as a method to examine the effect of treatment on vascular 
responses of coronary arteries in monkeys. Previous studies 
Ot~e~i~~~~de~~de~ arteries (13) a~ 
arteries Of hurn~n beings (j) an 
1 constrict in respcdnse to infusion of acetyl- 
resent data are consistent with these ~~di~~s 
bat ather0sclerosis impairs e~dOt~e~~~~~ 
f coronary arteries Of estrO- 
infusion Of ethinyl estra 
line of atherosclerotic c0r0- 
o dilation. These results are 
ous studies indicatirrg that 
mea pig uterine arteries (17) 
and rabbit ihiac arteries (18) in response to acetykzholine. 
~ccent~y. our group (7) repotted that long-term (2 years) 
coronary arteries of monkeys and human 
responses of cor0rr9;’ 
normal’y f~~ctio~i~g e~dotbei~~~~. e sonclude tha? infu- 
on endothelium-mediated vascula- responses of atheroscie- 
rotic coronary arteries. Bt is at estrogen has 
direct etkcts on the endotheli , our results do 
not rule out the possibility that en bad direct effects on 
muscarinic receptor activity of smooth muscle cells. 
Our data indicate that the effects of estrogen 
responses are not associated with 
tein concentr&ons. However, the 
the possibility that estrogen may 
teins in the arterict wall or through cts on monocyte- 
macrophage interactions. 
otentiol ed2anistns 
Althou& the means by which estrogen alters endothehum- 
mediated vascular responses of atherosclerotic coronary arter- 
ies was not addressed in this study, there are several p0ssible 
mechanisms. 
Plaagne size Long-term estrogen replacement in surf+ 
cafly postmenopausal fcmalc mQnkeys id3ibitS ~KI&JTS~iO~ 
of atherosclerosis (1%. Additionally, studies by Lopez et al. 
(20) indicated that e~dothelium”de~ende~t vascular re- 
sponses become more impai d as plaque size increas 
Therefore. tt may be speculat that the eiTect of estrogen 
vascular responses is the result of e cts of estrQge~ on 
plaque extent. However, the effects of long-term estrogen 
treatment on vascular response5 were not associated with 
effects of estrogen on plaque extent (7). It is unlikely that a 
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20-min exposure of arteries to ethiny! estradiol changed 
plaque size. Therefore, plaque size is an unlikely cause of 
estrogen’s effects on vascular responses of atherosclerotic 
coronary arteries. 
Lipids and lipoproteins. Premenopausal women and post- 
menopausal women taking estrogen replacement have higher 
HDL cholesterol concentrations and a lower incidence of 
coronary heart disease than their male counterparts (l-4). 
Estrogen’s effects on HDL cholesterol are thought to Partly 
explain its car&protective effects. It is established that 
varying concentrations of plasma lipids can modulate endo- 
thelium-media&d dilation of arteries (2 I ,22i. Results of the 
present experiment indicate that cthinyl estradioi did not 
Ghan&e plasma concentrations of total plasma cholesterol or 
HDL cholesterol. It sccn~ unlikely, in this experiment, that 
plasma concentrations of lipoproteins an‘ected vascular re- 
sponses. 
Athcr3si,Gcrotic Icsiotrs coniain many lcukocytcs. Cspc- 
cially in the early stages of athcrogenesis (23). Plasma lipids 
and lipoproteins in the arterial wall can alyect monocyte- 
macrophage interactions (23). Monocytes and macrophages 
release a variety of vasoactive substances (24). Lopez et al. 
(25) reported that atherosclerosis augments constriction to 
leukocyte products in the arteries of monkeys. More re- 
cently, it was reported (26) that estrogen inhibits uptake of 
and metabolism of LDL cholesterol in the arteries of female 
monkeys. It is unknown ifestrogen’s effects on plasma lipids 
in the artery wall may affect monocyte-macrophage interac- 
tions and, thereby, vascular responsiveness. 
Smooth muscle. There is evidence that the vascular 
smooth muscle is a target for estrogen. Estrogen and Pro- 
gesterone receptors have been found in the vascular smooth 
muscle cells of several mammalian sqecics (27.28). Estrogen 
treatment has resulted in a reduction in both lipoprotein- 
induced sortie smooth muscle proliferation (29) and myoin- 
timal proliferation associated with mechanical endothelial 
injury (30). It seems unlikely, however, that estrogen can 
influence the function or distribution of receptors within 
26 min of administration. However, it is unknown if estrogen 
and Progesteroor\e receptors play a role in modulating vascu- 
lar responses of arteries. The results of the present study do 
not rule out the possibility that other effects of estrogen on 
vascular smooth muscle modulated vascular responses to 
acetylcholine. 
A Preliminary study by Sang et al. (3 I) provided evidence 
that very large doses of estrogen promote endothelium- 
iIldepett&nt dilation of arteries. However. our data indicate 
that lower doses of estrogen do not affect dilation responses 
to nitroglycerin. In a study (7) of long-term effects of 
estrogen on vascular responses of atherosclerGtic coronary 
WtcrieS, eStrO&n was given in a sufficient dose to produce 
~Oncent~tiOnS similar to those achieved during the follicular 
Phase of the menstrual cycle (200 to 250 pglml of plasma) of 
women and monkeys. In the present study, ethinyl estradiol 
was given in doses similar to those found in oral contracep- 
tive agents. Neither long-term nor short-term estrogen treat- 
ment given at these doses altered smooth musc~e~med~ated 
vascular responses to nitrogiycerin. 
Our present results do not indicate whether estro 
modulates the function of mus inic receptors on en 
lial or smooth muscle cells. ever, results of i 
studies (7) indicated that estrogen promoted release of 
endothelium-derived relaxation factor tbro~gb receptor- 
independent mechanisms, suggesting that the primary action 
of ogen is on the endothel 
Estrogen has n shown to affect Prost 
cyciin production of uterine arteries (32). Prostanoids, sue 
as prostacyclin and thro 
the function of vascular 
al. (16) reported that au 
rotic arteries in response to acetylcholine by t 
ionophore A23187 was not attenuated by indo 
remains undetermined if estrogen modulates proslanoid pro- 
duction and functicn in atherosc~c~otic arteries. 
~el~xuti~n. It has been suggested (14) 
that atherosclerosis impairs e~dot~~elium-~ie~iated vascu 
responses by damaging lumen endothelial cells and there 
othelium-derived relaxation and con- 
gen may facilitate release or response 
ived relaxing factors or inhibit release of 
constrictor factors or both. A recent study by - et al. 
(33) suggested thtit cells or cell products in at lerotic 
arteries promote the breakdouh (1 of Gtric oxide (thought to 
be an endothelium-derived ic!nxing factor). It is known that 
estrogen is a potent antioxidant ot lip& (34) and oxidized 
lipids reduce nitric oxide activity (35). Estrogela may in 
ence vascular responses of atherosclerotic arteries by reduc- 
ing lipid peroxidation in the atherosclerotic arterial wall, 
thereby allowing more endothelium-derived relaxing factor 
to reach vascular smooth muscle. Plcliminary studies by 
Jiang et al. (3!,36) indicated that estrogen may act as a 
calcium antagonist and may inhibit constrictor responses to 
endothelium. It is possible that rapid effects of estrogen on 
vascular responses could be explained by calcium antagonist 
activity. 
Conclusions. The objective of the present study was to 
determine the effects of short-term administration of estro- 
gen on endothelium-mediated dilation in the coronary arter- 
ies of 13 ovariectomized cynomolgus monkeys. The arteries 
constricted in response to infusion of acetylcholine before 
estrogen treatment. but dilated 20 min after intravenous 
injection SC \;th;nyl estradiol (p < 0.05). Vascular responses 
of cora3llary arteries. both before and after administration of 
estrogen. were not associated with variations in plasma lipid 
c )ncentrations. blood pressure, heart rate or plaque size, It 
is concluded that short-term estrogen administration does 
affect endothelium-mediated dilation in this model and may 
have rapid direct effects on the vascular endothelium. Such 
rapid effects may be of clinical benefit if estrogen can be used 
on a short-term basis to reduce the risk of coronary artery 
vasospasm. 
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